Cargando…
Reorganization of 3D chromatin architecture in doxorubicin-resistant breast cancer cells
Background: Doxorubicin resistance remains a major therapeutic challenge leading to poor survival prognosis and treatment failure in breast cancer. Although doxorubicin induces massive changes in the transcriptional landscape are well known, potential diagnostic or therapeutic targets associated wit...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9393755/ https://www.ncbi.nlm.nih.gov/pubmed/36003143 http://dx.doi.org/10.3389/fcell.2022.974750 |